Status:
UNKNOWN
Role of Ajwa Derived Polyphenols in Dyslipidaemias
Lead Sponsor:
Aga Khan University
Conditions:
Dyslipidemias
Hyperglycemia
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
World Health Organization report notifies of the escalating global burden of cardiovascular diseases (CVD), projecting that it will become the major worldwide cause of death and disability by 2020. Th...
Detailed Description
Overall lipid profile is important in cardiovascular diseases but particularly serum HDL levels have long been recognized as an independent inverse prognostic marker of CVD, when the Framigham study, ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- General population from AKU with serum HDL \< 40 mg/dl for men and women
- Adult ages (18- 70years ) will be included in the study.
- EXCLUSION CRITERIA:
- Individuals with Dates/Ajwa allergy
- Individuals Patients already taking regular Ajwa
- Pregnant women and individuals with diabetes, metabolic syndrome or any other co-morbidity will be excluded.
Exclusion
Key Trial Info
Start Date :
March 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 7 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03805139
Start Date
March 20 2019
End Date
December 7 2019
Last Update
November 12 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aga Khan University
Karachi, Sindh, Pakistan, 74800